BE685228A - - Google Patents

Info

Publication number
BE685228A
BE685228A BE685228DA BE685228A BE 685228 A BE685228 A BE 685228A BE 685228D A BE685228D A BE 685228DA BE 685228 A BE685228 A BE 685228A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE685228A publication Critical patent/BE685228A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE685228D 1965-08-09 1966-08-08 BE685228A (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US478437A US3365365A (en) 1965-08-09 1965-08-09 Repeat action pharmaceutical compositions in the form of discrete beadlets

Publications (1)

Publication Number Publication Date
BE685228A true BE685228A (hr) 1967-02-08

Family

ID=23899930

Family Applications (1)

Application Number Title Priority Date Filing Date
BE685228D BE685228A (hr) 1965-08-09 1966-08-08

Country Status (5)

Country Link
US (1) US3365365A (hr)
BE (1) BE685228A (hr)
BR (1) BR6681937D0 (hr)
ES (1) ES330013A1 (hr)
NL (1) NL6611190A (hr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085672A1 (hr) * 1970-03-05 1971-12-31 Hoechst Ag
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament
AU617417B2 (en) * 1987-11-16 1991-11-28 Baxter International Inc. Glassy matrix for administration of beneficial agent
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
CA2645855C (en) 2006-03-16 2015-02-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
EP2726066B1 (en) 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosage forms of amphetamine for oral administration
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
IT201700048797A1 (it) * 2017-05-05 2018-11-05 Neilos S R L Sistema di rilascio controllato di ingredienti attivi a base di materiali polimerici e suo impiego in campo nutraceutico.
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043747A (en) * 1958-10-22 1962-07-10 Upjohn Co Tablets coated with carboxymethylcellulose shellac composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085672A1 (hr) * 1970-03-05 1971-12-31 Hoechst Ag
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition

Also Published As

Publication number Publication date
ES330013A1 (es) 1967-06-16
NL6611190A (hr) 1967-02-10
BR6681937D0 (pt) 1973-10-25
US3365365A (en) 1968-01-23

Similar Documents

Publication Publication Date Title
CS166194B2 (hr)
AU407295B2 (hr)
JPS4520573Y1 (hr)
JPS4425210Y1 (hr)
JPS4513959Y1 (hr)
BE675324A (hr)
JPS435720Y1 (hr)
JPS4331493Y1 (hr)
JPS434614B1 (hr)
FI43105B (hr)
JPS4428220Y1 (hr)
JPS4518196B1 (hr)
BE675724A (hr)
BE674464A (hr)
NL6513002A (hr)
NL6611190A (hr)
NL6601253A (hr)
NL6602285A (hr)
NL6603585A (hr)
NL6604146A (hr)
NL6606241A (hr)
BE674459A (hr)
BE688192A (hr)
BE676891A (hr)
BE674412A (hr)